Mutant p53 protein enables the acceleration of tumor formation and metastasis and is associated with resistance to radiotherapy and chemotherapy, as well as poor prognosis (Al-Sukhun and Hussain, 2003). The gene discussed is TP53; the disease is neoplasm.